Purchase Link:
http://www.research-store.com/fiercebiotech/Product/point_of_care_testing_evaluating_the_return_to_evidence_based_medicine_novel_technologies_and_the_competitive_landscape?productid=A2A641CF-CBC6-40C3-A632-686F05EC0BD6
Introduction
Diagnostic practice is undergoing a quiet revolution, with in-vitro diagnostic (IVD) tests moving out of the centralized hospital laboratory to POCT locations. POC tests are more expensive than lab-based tests, but promise to reduce the overall cost of healthcare while improving the quality of outcomes. They are thus attractive to manufacturers and increasingly in demand.
Scope of this research
- Details of different types of POCT technologies and the information they provide in clinical situations.
- Analysis of current market satisfaction, areas of need and competition for POCT in various therapy areas.
- Examination of the analytes/biomarkers incorporated into commercial POCT products on the market and in commercial development.
- Profiles of the activities and strategies of 40 companies that are making an impact in the POCT market.
- Forecasts for the POCT market to 2013 by major market segments and geographic areas.
Research and analysis highlights
In most countries, the average spending on IVDs is a very low percentage of the national healthcare budget, but spending on POC IVDs that offer speed, convenience and improved outcomes is set to grow at an increased rate.
Since 2006, wider adoption of POCT in the US has been driven by the issuance of testing guidelines by the National Academy of Clinical Biochemistry. The US now represents more than half of the global POCT market.
Expanding medical and non-medical POCT locations, which include fast-growing retail health clinics in the US, provide new marketing opportunities for manufacturers of POC tests.
Key reasons to purchase this research
- Understand the role of POC tests in diagnosis and monitoring in different clinical situations.
- Gain an insight into how the market for POC tests is shaping up in each of the major application areas.
- Identify competitors or potential collaborators developing improved or novel POC technologies and products.
- Assess established and emerging marketing channels for POC tests.
- Understand the characteristics of different geographical markets and individual POCT market sectors.
Teaser:
Diagnostic practice is undergoing a quiet revolution, with in-vitro diagnostic (IVD) tests moving out of the centralized hospital laboratory to POCT locations. POC tests are more expensive than lab-based tests, but promise to reduce the overall cost of healthcare while improving the quality of outcomes. They are thus attractive to manufacturers and increasingly in demand.
